Catherine A. Evans

1.2k total citations
16 papers, 887 citations indexed

About

Catherine A. Evans is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Catherine A. Evans has authored 16 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Catherine A. Evans's work include Bone health and treatments (5 papers), Chemical Synthesis and Analysis (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Catherine A. Evans is often cited by papers focused on Bone health and treatments (5 papers), Chemical Synthesis and Analysis (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Catherine A. Evans collaborates with scholars based in United States and United Kingdom. Catherine A. Evans's co-authors include Scott J. Miller, Ingunn Holen, Robert E. Coleman, Helen Neville-Webbe, Elizabeth R. Jarvo, Diane V. Lefley, Gregory T. Copeland, Amin Rostami‐Hodjegan, Penelope D. Ottewell and Marta Nevalainen and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and PLoS ONE.

In The Last Decade

Catherine A. Evans

16 papers receiving 880 citations

Peers

Catherine A. Evans
Vadim Divilov United States
Nathan C. Ihle United States
Laurence Carroll United Kingdom
Juozas Domarkas United Kingdom
Christopher D'Souza United States
Mark J. Mulvihill United States
Bernard Barlaam United Kingdom
Catherine A. Evans
Citations per year, relative to Catherine A. Evans Catherine A. Evans (= 1×) peers Curtis Harwig

Countries citing papers authored by Catherine A. Evans

Since Specialization
Citations

This map shows the geographic impact of Catherine A. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine A. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine A. Evans more than expected).

Fields of papers citing papers by Catherine A. Evans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine A. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine A. Evans. The network helps show where Catherine A. Evans may publish in the future.

Co-authorship network of co-authors of Catherine A. Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine A. Evans. A scholar is included among the top collaborators of Catherine A. Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine A. Evans. Catherine A. Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Tulotta, Claudia, Diane V. Lefley, Russell Hughes, et al.. (2021). IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer. npj Breast Cancer. 7(1). 95–95. 38 indexed citations
2.
Uehara, Mayuko, Martina M. McGrath, Shunsuke Ohori, et al.. (2017). Regulation of T cell alloimmunity by PI3Kγ and PI3Kδ. Nature Communications. 8(1). 951–951. 26 indexed citations
3.
Evans, Catherine A., Simon J. Cook, Michel P. Coleman, & Jonathan Gilley. (2013). MEK Inhibitor U0126 Reverses Protection of Axons from Wallerian Degeneration Independently of MEK–ERK Signaling. PLoS ONE. 8(10). e76505–e76505. 6 indexed citations
4.
Evans, Catherine A., et al.. (2009). Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy. Cancer Chemotherapy and Pharmacology. 65(5). 969–978. 23 indexed citations
5.
Ottewell, Penelope D., Diane V. Lefley, Simon S. Cross, et al.. (2009). Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model. International Journal of Cancer. 126(2). 522–532. 64 indexed citations
6.
Ottewell, Penelope D., Julia K. L. Woodward, Diane V. Lefley, et al.. (2009). Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone. Molecular Cancer Therapeutics. 8(10). 2821–2832. 67 indexed citations
7.
Linton, Brian R., Christopher M. Aderman, Elizabeth Richardson, et al.. (2007). Asymmetric Michael addition of α-nitro-ketones using catalytic peptides. Tetrahedron Letters. 48(11). 1993–1997. 40 indexed citations
8.
Nevalainen, Marta, et al.. (2006). A new organocatalyst for 1,3-dipolar cycloadditions of nitrones to α,β-unsaturated aldehydes. Tetrahedron Letters. 48(2). 277–280. 78 indexed citations
9.
Holen, Ingunn, Simon S. Cross, Helen Neville-Webbe, et al.. (2005). Osteoprotegerin (OPG) Expression by Breast Cancer Cells in vitro and Breast Tumours in vivo – A Role in Tumour Cell Survival?. Breast Cancer Research and Treatment. 92(3). 207–215. 96 indexed citations
10.
Evans, Catherine A., Bryan J. Cowen, & Scott J. Miller. (2005). Diversity-generation from an allenoate–enone coupling: syntheses of azepines and pyrimidones from common precursors. Tetrahedron. 61(26). 6309–6314. 21 indexed citations
11.
Neville-Webbe, Helen, Amin Rostami‐Hodjegan, Catherine A. Evans, Robert E. Coleman, & Ingunn Holen. (2004). Sequence‐ and schedule‐dependent enhancement of zoledronic acid induced apoptosis by doxorubicin in breast and prostate cancer cells. International Journal of Cancer. 113(3). 364–371. 126 indexed citations
12.
Evans, Catherine A. & Scott J. Miller. (2003). Amine-Catalyzed Coupling of Allenic Esters to α,β-Unsaturated Carbonyls. Journal of the American Chemical Society. 125(41). 12394–12395. 107 indexed citations
13.
Evans, Catherine A. & Scott J. Miller. (2002). Proton-activated fluorescence as a tool for simultaneous screening of combinatorial chemical reactions. Current Opinion in Chemical Biology. 6(3). 333–338. 33 indexed citations
14.
Kozlowski, Marisa C., et al.. (2002). Computer-Aided Design of Chiral Ligands. Part III. A Novel Ligand for Asymmetric Allylation Designed Using Computational Techniques. Organic Letters. 4(25). 4391–4393. 19 indexed citations
15.
Jarvo, Elizabeth R., Catherine A. Evans, Gregory T. Copeland, & Scott J. Miller. (2001). Fluorescence-Based Screening of Asymmetric Acylation Catalysts through Parallel Enantiomer Analysis. Identification of a Catalyst for Tertiary Alcohol Resolution. The Journal of Organic Chemistry. 66(16). 5522–5527. 116 indexed citations
16.
Papaioannou, Nikolaos, Catherine A. Evans, Jarred T. Blank, & Scott J. Miller. (2001). Enantioselective Synthesis of a Mitosane Core Assisted by Diversity-Based Catalyst Discovery. Organic Letters. 3(18). 2879–2882. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026